aTyr Pharma, Inc. financial statements
aTyr Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 190K | 10-K |
| Net income | −USD 74.12M | 10-K |
| Cash and equivalents | USD 10.74M | 10-Q |
| Total debt | USD 12.03M | EODHD |
aTyr Pharma, Inc. financials on 6ix · aTyr Pharma, Inc. on 6ix